Skip to content

LC-MS based metabolonics strategy to assess severity and prognosis of hyperlipidemic pancreatitis

LC-MS based metabolonics strategy to assess severity and prognosis of hyperlipidemic pancreatitis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054641
Enrollment
Unknown
Registered
2021-12-22
Start date
2018-01-01
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

HTG group:None
Acute pancreatitisgroup:None

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the AP diagnostic criteria; 2. Meet the diagnostic criteria for high-fat pancreatitis as follows: triglyceride level (TG) > 11.3 mmol/L or serum chyle-like; 3. After fasting and other factors, the patient's serum triglyceride (TG) is between 5.65-11.3mmol/L.

Exclusion criteria

Exclusion criteria: 1. Pancreatitis of other etiologies; 2. The patient has immunodeficiency. Immune-related diseases such as AIDS, idiopathic reaction, asthma, rheumatoid arthritis; 3. Diabetes, thyroid disease; 4. Malignant tumors include leukemia, lymphoma, myeloma, etc.; 5. Mental illness; 6. Pregnancy; 7. Can not cooperate to complete the task.

Design outcomes

Primary

MeasureTime frame
metabolite;

Countries

China

Contacts

Public ContactZeng Yue

Shanghai First People's Hospital

carrie_1004@163.com+86 18621625166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026